DexCom Inc (DXCM NASDAQ) stock market data APIs
$79.6127
-0.26(-0.3%)
as of October 29, 2026
Try our APIs with
free plan!
DexCom Inc Financial Data Overview
Price chart is built with
Anychart
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Prev. Close
79.6127
Open
79.3489
High
79.6179
Low
77.9903
52 wk Range
54.11-92.59
Market Cap
29 668 M
P/E Ratio
31.1984
Shares Outstanding
377 M
Revenue
4 969 M
Beta
1.477
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with DexCom Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get DexCom Inc data using free add-ons & libraries
Get DexCom Inc Fundamental Data
DexCom Inc Fundamental data includes:
- Net Revenue: 4 969 M
- EBITDA: 1 403 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-10-29
- EPS/Forecast: 0.66
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DexCom Inc News
New
Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch in Canada in November
Dexcom G7 15 Day combines industry leading sensor duration with best-in-class accuracy, giving Canadians living with diabetes more time between sensor changes and fewer interruptions to daily routines...
AxoGen (AXGN) Beats Q3 Earnings and Revenue Estimates
AxoGen (AXGN) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.12 per share a year ago. These figures are a...
What to expect from DexCom’s (DXCM) Q3 earnings
What to expect from DexCom's (DXCM) Q3 earnings Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Thursday after the bell. Here's what investors should know. DexCom beat ana...
DexCom Gears Up to Report Q3 Results: How to Play the Stock?
DexCom, Inc. DXCM is scheduled to report third-quarter 2026 results on Oct. 29, after the closing bell. In the last reported quarter, the company's adjusted earnings per share (EPS) of 70 cents surpa...
Get DexCom Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.